Stem Cell-based Therapies for CF, Other Diseases Supported by $20.5M in Grants from CIRM – Cystic Fibrosis News Today
|
Stem Cell-based Therapies for CF, Other Diseases Supported by $20.5M in Grants from CIRM
Cystic Fibrosis News Today Matthew Porteus, MD, associate professor of pediatrics at Stanford, received $2.2 million to investigate the use of gene editing to correct CF mutations in airway stem cells. Such research has begun to demonstrate the possibility of replacing mutated … |
